FERI (Luxembourg) S.A.’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,610
Closed -$2.07M – 123
2026
Q2
$2.07M Buy
+10,610
New +$2.2M 0.33% 73
2025
Q4
– Sell
-5,830
Closed -$1.6M – 92
2025
Q3
$1.6M Buy
5,830
+350
+6% +$95.6K 0.46% 65
2025
Q2
$1.41M Buy
5,480
+1,900
+53% +$453K 0.45% 59
2025
Q1
$801K Sell
3,580
-1,140
-24% -$266K 0.28% 78
2024
Q4
$1.08M Buy
+4,720
New +$1.14M 0.6% 50

Other funds holding RMD

FERI (Luxembourg) S.A.'s RMD Position: Q3 2026 in Review

FERI (Luxembourg) S.A. sold out of ResMed (RMD) in Q3 2026, closing a stake of 10,610 shares — an estimated $2.07M sold.

FERI (Luxembourg) S.A. first reported a position in RMD in Q4 2024 and held it in 5 quarters. The position peaked at $2.07M in Q2 2026. 816 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • FERI (Luxembourg) S.A. reported no remaining ResMed position as of Q3 2026 after selling out during the quarter.
  • FERI (Luxembourg) S.A. sold 10,610 ResMed shares in Q3 2026, an estimated $2.07M.
  • FERI (Luxembourg) S.A. first reported a position in ResMed in Q4 2024 and held it in 5 quarters.
  • FERI (Luxembourg) S.A.'s ResMed position peaked at $2.07M in Q2 2026.
  • 816 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on FERI (Luxembourg) S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.